165 related articles for article (PubMed ID: 19085457)
21. Combination therapy in the treatment of experimental invasive fungal infection by Sarocladium (Acremonium) kiliense.
Fernández-Silva F; Capilla J; Mayayo E; Sutton D; Guarro J
Int J Antimicrob Agents; 2014 Aug; 44(2):136-9. PubMed ID: 24837411
[TBL] [Abstract][Full Text] [Related]
22. [Progress in combination therapy for invasive aspergillosis].
Luo L; Tong Z
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):41-4. PubMed ID: 24694973
[No Abstract] [Full Text] [Related]
23. Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species.
Calvo E; Pastor FJ; Guarro J
J Antimicrob Chemother; 2010 Jul; 65(7):1455-9. PubMed ID: 20488983
[TBL] [Abstract][Full Text] [Related]
24. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
[TBL] [Abstract][Full Text] [Related]
25. Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana.
Al-Abdely HM; Najvar LK; Bocanegra R; Graybill JR
Antimicrob Agents Chemother; 2005 May; 49(5):1701-7. PubMed ID: 15855484
[TBL] [Abstract][Full Text] [Related]
26. Antifungal agents used for deep-seated mycotic infections.
Terrell CL; Hermans PE
Mayo Clin Proc; 1987 Dec; 62(12):1116-28. PubMed ID: 3682956
[TBL] [Abstract][Full Text] [Related]
27. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
Salas V; Pastor FJ; Calvo E; Sutton D; García-Hermoso D; Mayayo E; Dromer F; Fothergill A; Alvarez E; Guarro J
Med Mycol; 2012 Oct; 50(7):710-5. PubMed ID: 22458251
[TBL] [Abstract][Full Text] [Related]
28. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887
[TBL] [Abstract][Full Text] [Related]
29. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
[TBL] [Abstract][Full Text] [Related]
31. Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis.
Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Denning DW; Drusano GL
J Infect Dis; 2005 Aug; 192(4):673-80. PubMed ID: 16028137
[TBL] [Abstract][Full Text] [Related]
32. Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine.
Ruíz-Cendoya M; Pastor FJ; Capilla J; Guarro J
Int J Antimicrob Agents; 2011 Jan; 37(1):58-61. PubMed ID: 20947310
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Jullien V
Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286
[TBL] [Abstract][Full Text] [Related]
34. Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii.
Calvo E; Pastor FJ; Salas V; Mayayo E; Capilla J; Guarro J
J Antimicrob Chemother; 2012 Mar; 67(3):666-70. PubMed ID: 22190608
[TBL] [Abstract][Full Text] [Related]
35. [Principles of the treatment of organic and systemic mycoses].
Pawlik B; Laskownicka Z
Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):727-31. PubMed ID: 2084628
[No Abstract] [Full Text] [Related]
36. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
37. The value of amphotericin B in the treatment of invasive fungal infections.
Klepser M
J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
[TBL] [Abstract][Full Text] [Related]
38. Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
Trinh JV; Steinbach WJ; Schell WA; Kurtzberg J; Giles SS; Perfect JR
Med Mycol; 2003 Aug; 41(4):339-45. PubMed ID: 12964727
[TBL] [Abstract][Full Text] [Related]
39. Fatal cerebral abscess caused by Cladophialophora bantiana.
George IA; Mathews MS; Karthik R; John L; Sundar A; Abraham OC; Joseph V
J Assoc Physicians India; 2008 Jun; 56():470-2. PubMed ID: 18822631
[TBL] [Abstract][Full Text] [Related]
40. Combinations of antifungal agents in therapy--what value are they?
Cuenca-Estrella M
J Antimicrob Chemother; 2004 Nov; 54(5):854-69. PubMed ID: 15375111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
